In addition, activation of CYP7A1 in the liver leads to the accumulation of secondary BAs in plasma, which may contribute to the hypoglycemic and anti-obesity activities of FA. This evidence concerns the gene CYP7A1 and obesity due to melanocortin 4 receptor deficiency.